Talk Bio – Page 295 – Actionable Insights Powered by AI

Fujifilm Diosynth Biotechnologies, $1.2 billion expansion, North Carolina, Holly Springs, 1/400 jobs, Biopharmaceutical manufacturing, End-to-end cell culture CDMO facility, Japanese investment

AstraZeneca’s FASENRA Gains FDA Approval for Add-On Maintenance Treatment of Severe Asthma in Children Aged 6-11

1 year ago talkbio0Tagged Age, Approved, AstraZeneca, benralizumab, Child, expansion, Fasenra, Pediatric Label, Severe asthma, United States Food and Drug Administration

AstraZeneca, FASENRA, Benralizumab, Severe Asthma, Pediatric Label Expansion, FDA Approval, Children Aged 6-11

Enlivex Stock Plunges 50% Following Mixed Phase II Sepsis Results for Allocetra Cell Therapy

1 year ago talkbio0Tagged Allocetra Cell Therapy, Enlivex, Phase 2 Clinical Trials, Septic Shock, Septicemia, Stock Plummet, Urinary tract infection

Enlivex Therapeutics, Allocetra Cell Therapy, Phase II Study, Sepsis Treatment, Stock Plummet, Mixed Results, Septic Shock, Urinary Tract Infection (UTI)

Adaptimmune Terminates $3 Billion Collaboration with Roche’s Genentech for Off-the-Shelf T Cell Therapies

1 year ago talkbio0Tagged Adaptimmune, Collaboration termination, genentech, Papillary thyroid carcinoma, Roche (company), T cell therapies

Adaptimmune, Roche, Genentech, Off-the-shelf T cell therapies, $3 billion biobucks pact, Collaboration termination

Eli Lilly’s State Law Attempt to Halt Florida Compounding Pharmacy’s Tirzepatide Sales Dismissed

1 year ago talkbio0Tagged Cosmetic Act, eli lilly, FDCA, Florida compounding pharmacy, Frivolous lawsuits, Judge Roy Altman, Mounjaro/ Zepbound, RXCompoundStore.com, tirzepatide

Eli Lilly, Florida compounding pharmacy, RXCompoundStore.com, Tirzepatide (Mounjaro/ Zepbound), Judge Roy Altman, Federal Food/ Drug/ and Cosmetic Act (FDCA), Frivolous lawsuits

Amylyx Reveals Interim Rare Disease Data for Withdrawn ALS Therapy

1 year ago talkbio0Tagged Amylyx, Amyotrophic Lateral Sclerosis, Infrequent, Interim, Rare neurological disorder, Withdraw (activity)

Amylyx, Rare disease data, ALS drug withdrawal, Interim results, Rare neurological disorder

Record-Breaking 323 Medications in Active Shortage in US, ASHP Reports

1 year ago talkbio0Tagged Active shortages, Adderall, American Society of Health-System Pharmacists, Antineoplastic Agents, ASHP, Attention deficit hyperactivity disorder, Drug Enforcement Administration, Drug shortages, Drug supply chains, Generic sterile injectable medications, Policy, Recommendation, Record-high

Drug shortages, US, Record-high, American Society of Health-System Pharmacists (ASHP), 323 medications, Active shortages, Generic sterile injectable medications, Cancer chemotherapy drugs, ADHD medications, Adderall, Drug Enforcement Administration (DEA), Drug supply chains, Policy recommendations